Synopsis
Synopsis
0
KDMF
0
VMF
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Baysilon
2. Macroplastique
3. Poly(dimethylsiloxane)
4. Polydimethylsiloxane
5. Rtv S-5392
6. Silastic
7. Siliconique
8. Silikon 1000
9. Simpa
1. 107-51-7
2. Trisiloxane, Octamethyl-
3. Poly(dimethylsiloxane)
4. 1,1,1,3,3,5,5,5-octamethyltrisiloxane
5. Dimeticone
6. Dimethyl-bis(trimethylsilyloxy)silane
7. Dimethicone 350
8. 63148-62-9
9. Pentamethyl(trimethylsilyloxy)disiloxane
10. Dimethylbis(trimethylsiloxy)silane
11. 9g1zw13r0g
12. Chebi:9147
13. Trisiloxane, 1,1,1,3,3,5,5,5-octamethyl-
14. Dimethylbis(trimethylsilyloxy)silane
15. Dimethicones
16. Poly(dimethylsiloxane), Hydroxy Terminated
17. Mfcd00084411
18. Mfcd00134211
19. Mfcd00148360
20. Ccris 3198
21. Poly(dimethylsiloxane), Trimethylsiloxy Terminated
22. Einecs 203-497-4
23. Dimeticonum
24. Unii-9g1zw13r0g
25. Dimeticona
26. Frd 20
27. Ctamethyltrisiloxane
28. Mfcd00008264
29. Pentamethyl(trimethylsiloxy)disiloxane
30. Octamethyl-trisiloxane
31. Pdms
32. Dimethicone Macromolecule
33. Volasil Dm-1
34. Silicon Oil For Oil Bath
35. Trisiloxane [inci]
36. Dm-fluid 1.0cs
37. Ec 203-497-4
38. Octamethyltrisiloxane, 98%
39. Dsstox_cid_20710
40. Dsstox_rid_79558
41. Dsstox_gsid_40710
42. Os 20 (siloxane)
43. Schembl23459
44. Siliconoil Pharma 100 Cst.
45. Dimethyl Polysiloxane, Bis(trimethylsilyl)-terminated
46. Dow Corning High-vacuum Grease
47. Chembl2142985
48. Dtxsid9040710
49. Chebi:31498
50. Cxqxsvuqtkdnfp-uhfffaoysa-
51. Kf 96a1
52. Octamethyltrisiloxane [mi]
53. Dimethylbis(trimethylsiloxy)siliane
54. Polydimethylsiloxane, 1000 Cst.
55. Alpha-(trimethylsilyl)-omega-methylpoly(oxy(dimethylsilylene))
56. [(ch3)3sio]2si(ch3)2
57. Tox21_301002
58. Co9816
59. Mfcd00165850
60. Silane, Dimethylbis(trimethylsiloxy)-
61. Akos015840180
62. Zinc169747808
63. Antifoam Compound For Anhydrous Systems
64. Fs-4459
65. Ncgc00164100-01
66. Ncgc00164100-02
67. Ncgc00254904-01
68. Cas-107-51-7
69. Db-040764
70. Ft-0631598
71. Ft-0696355
72. O0257
73. O9816
74. C07261
75. D91850
76. S12475
77. A801717
78. Xiameter(r) Pmx-200 Silicone Fluid 1 Cst
79. J-001906
80. Poly(dimethylsiloxane), Viscosity 1.0 Cst (25 C)
81. Q2013799
82. Xiameter(r) Pmx-200 Silicone Fluid 20 Cs
83. 2,2,4,4,6,6-hexamethyl-3,5-dioxa-2,4,6-trisilaheptane
84. Polydimethylsiloxane, 20,000 Cst. Trimethoxysilyl Terminated
85. Polydimethylsiloxane, Extreme Low Volatility, Viscosity 1000 Cst.
86. Intermediate Viscosity Polydimethylsiloxane Antifoam Emulsion, 20% Active, Viscosity 1500cst
87. Intermediate Viscosity Polydimethylsiloxane Antifoam Emulsion, 30% Active, Viscosity 1500cst
88. Polydimethylsiloxane, Trimethylsiloxy Terminated, Reduced Volatility, Viscosity 20 Cst.
89. 28349-86-2
90. Intermediate Viscosity Polydimethylsiloxane Antifoam Emulsion, 10% Active, Viscosity 1000-2000cst
91. Intermediate Viscosity Polydimethylsiloxane Antifoam Emulsion, 10% Active, Viscosity 800-2000cst
92. Intermediate Viscosity Polydimethylsiloxane Antifoam Emulsion, 20% Active, Viscosity 1000-2000cst
93. Intermediate Viscosity Polydimethylsiloxane Antifoam Emulsion, 30% Active, Viscosity 1000-2000cst
94. Polydimethylsiloxane, Trimethylsiloxy Terminated, Extreme Low Volatility, Viscosity 12.500 Cst.
Molecular Weight | 236.53 g/mol |
---|---|
Molecular Formula | C8H24O2Si3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Exact Mass | 236.10840961 g/mol |
Monoisotopic Mass | 236.10840961 g/mol |
Topological Polar Surface Area | 18.5 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 149 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
P - Antiparasitic products, insecticides and repellents
P03 - Ectoparasiticides, incl. scabicides, insecticides and repellents
P03A - Ectoparasiticides, incl. scabicides
P03AX - Other ectoparasiticides, incl. scabicides
P03AX05 - Dimeticone
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1499
Submission : 1970-03-06
Status : Active
Type : IV
Registration Number : 303MF10091
Registrant's Address : 974 Center Road, Wilmington, DE 19805, USA
Initial Date of Registration : 2021-06-07
Latest Date of Registration :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18688
Submission : 2005-08-05
Status : Active
Type : II
Date of Issue : 2024-05-07
Valid Till : 2027-04-24
Written Confirmation Number : WC-0418
Address of the Firm :
NDC Package Code : 44331-5001
Start Marketing Date : 2017-10-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30950
Submission : 2016-08-29
Status : Active
Type : II
Date of Issue : 2024-05-07
Valid Till : 2027-04-24
Written Confirmation Number : WC-0418
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9465
Submission : 1991-12-19
Status : Inactive
Type : II
Registration Number : 303MF10087
Registrant's Address : 974 Center Road, Wilmington, DE 19805, USA
Initial Date of Registration : 2021-06-03
Latest Date of Registration :
Certificate Number : R2-CEP 1995-047 - Rev 02
Issue Date : 2019-03-04
Type : Chemical
Substance Number : 138
Status : Valid
Certificate Number : R2-CEP 1995-049 - Rev 02
Issue Date : 2019-03-06
Type : Chemical
Substance Number : 30108
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18688
Submission : 2005-08-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30950
Submission : 2016-08-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9465
Submission : 1991-12-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1499
Submission : 1970-03-06
Status : Active
Type : IV
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : AHMC 0600 is a co-processed aluminum hydroxide and magnesium carbonate powder used in immediate-relief antacid tablet formulation.
Pharmacopoeia Ref : NA
Technical Specs : Apparent Density: 0.30-0.40 (g/mL)
Ingredient(s) : Aluminum Hydroxide Excipient
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : AHMC 0611 is a co-processed aluminum hydroxide & magnesium carbonate micronized powder used in immediate-relief antacid tablets & liquid suspensions.
Pharmacopoeia Ref : NA
Technical Specs : Tapped NMT: 0.2
Ingredient(s) : Aluminum Hydroxide Excipient
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : CM90 is a directly compressible, granulated calcium carbonate with maltodextrin used for swallow tablets due to its high density and compressibility.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 490- 500 µm; Tapped Density: 1.50
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-170 µm, Tapped Density: 0.80
Ingredient(s) : Magnesium Hydroxide Excipient
Dosage Form : Gel
Grade : Oral
Application : Thickeners and Stabilizers
Excipient Details : SPI® VAC Gels are based on highly engineered pseudo-boehmite and are used as vaccine adjuvants.
Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Topical, Parenteral
Category : Parenteral, Topical
Application : Topical
Excipient Details : L-Alanine is used in topical semi-solid dosage forms such as creams, lotions, ointments, gels, etc.
Application : Topical
Excipient Details : L-Glutamic acid is used in topical dosage forms such as lotions, soaps, creams, patches, etc.
Pharmacopoeia Ref : NA
Technical Specs : Molecular weight: 147.1 g/mol
Ingredient(s) : L-Glutamic Acid Excipient
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders
Application : Topical
Excipient Details : Aquapol® SF-1 is used in gel based ointments, solutions and other topical dosage forms.
Dosage Form : Cream / Lotion / Ointment, Ophthalmic Solution
Grade : Topical, Parenteral
Category : Solubilizers, Topical
Application : Topical
Excipient Details : Inositol is used in topical dosage forms such as creams, lotions and ointments.
Application : Topical
Excipient Details : L-lysine is used in the production of topical semi-solid dosage forms such as creams, lotions and ointments.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Tablet
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Thickeners and Stabilizers, Topical
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders
Application : Fillers, Diluents & Binders, Taste Masking
Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Solution, Tablet
Grade : Topical, Oral
Category : API Stability Enhancers, Emulsifying Agents, Fillers, Diluents & Binders
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Fillers, Diluents & Binders, Granulation, Solubilizers
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Application : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Capsule, Granule / Pellet, Tablet, Injectable / Parenteral
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Thickeners and Stabilizers
Application : Co-Processed Excipients
Excipient Details : Mannitol is a co-processed excipient with superior compactibility, lower disintegration time, and hygroscopicity.
Dosage Form : Liquid, Orodispersible Tablet, Suspension, Syrup, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Taste Masking
Dosage Form : Cream / Lotion / Ointment, Suspension
Grade : Topical
Category : API Stability Enhancers, Thickeners and Stabilizers
Dosage Form : Capsule, Granule / Pellet, Suspension, Syrup, Tablet
Grade : Oral
Category : Coating Systems & Additives, Fillers, Diluents & Binders, Taste Masking, Thickeners and Stabilizers
Application : Thickeners and Stabilizers
Excipient Details : SPI® VAC Gels are based on highly engineered pseudo-boehmite and are used as vaccine adjuvants.
Application : Rheology Modifiers, Thickeners and Stabilizers
Excipient Details : Blanose CMC 7MF is used as a thickener and viscosity modifier in liquid formulations such as suspensions.
Pharmacopoeia Ref : EP, USP/NF
Technical Specs : N/A
Ingredient(s) : Sodium Carboxymethyl Cellulose Excipient
Dosage Form : Cream / Lotion / Ointment, Capsule, Gel, Tablet
Grade : Oral, Topical
Category : API Stability Enhancers, Thickeners and Stabilizers
Application : Parenteral
Excipient Details : L-arginine is used as a cryoprotective agent and solution additive to help stabilize proteins against aggregation.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
38
PharmaCompass offers a list of Dimethicone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dimethicone manufacturer or Dimethicone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dimethicone manufacturer or Dimethicone supplier.
PharmaCompass also assists you with knowing the Dimethicone API Price utilized in the formulation of products. Dimethicone API Price is not always fixed or binding as the Dimethicone Price is obtained through a variety of data sources. The Dimethicone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DIMETHYLPOLYSILOXANE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DIMETHYLPOLYSILOXANE, including repackagers and relabelers. The FDA regulates DIMETHYLPOLYSILOXANE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DIMETHYLPOLYSILOXANE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DIMETHYLPOLYSILOXANE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DIMETHYLPOLYSILOXANE supplier is an individual or a company that provides DIMETHYLPOLYSILOXANE active pharmaceutical ingredient (API) or DIMETHYLPOLYSILOXANE finished formulations upon request. The DIMETHYLPOLYSILOXANE suppliers may include DIMETHYLPOLYSILOXANE API manufacturers, exporters, distributors and traders.
click here to find a list of DIMETHYLPOLYSILOXANE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DIMETHYLPOLYSILOXANE DMF (Drug Master File) is a document detailing the whole manufacturing process of DIMETHYLPOLYSILOXANE active pharmaceutical ingredient (API) in detail. Different forms of DIMETHYLPOLYSILOXANE DMFs exist exist since differing nations have different regulations, such as DIMETHYLPOLYSILOXANE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DIMETHYLPOLYSILOXANE DMF submitted to regulatory agencies in the US is known as a USDMF. DIMETHYLPOLYSILOXANE USDMF includes data on DIMETHYLPOLYSILOXANE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DIMETHYLPOLYSILOXANE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DIMETHYLPOLYSILOXANE suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The DIMETHYLPOLYSILOXANE Drug Master File in Japan (DIMETHYLPOLYSILOXANE JDMF) empowers DIMETHYLPOLYSILOXANE API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the DIMETHYLPOLYSILOXANE JDMF during the approval evaluation for pharmaceutical products. At the time of DIMETHYLPOLYSILOXANE JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of DIMETHYLPOLYSILOXANE suppliers with JDMF on PharmaCompass.
A DIMETHYLPOLYSILOXANE CEP of the European Pharmacopoeia monograph is often referred to as a DIMETHYLPOLYSILOXANE Certificate of Suitability (COS). The purpose of a DIMETHYLPOLYSILOXANE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DIMETHYLPOLYSILOXANE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DIMETHYLPOLYSILOXANE to their clients by showing that a DIMETHYLPOLYSILOXANE CEP has been issued for it. The manufacturer submits a DIMETHYLPOLYSILOXANE CEP (COS) as part of the market authorization procedure, and it takes on the role of a DIMETHYLPOLYSILOXANE CEP holder for the record. Additionally, the data presented in the DIMETHYLPOLYSILOXANE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DIMETHYLPOLYSILOXANE DMF.
A DIMETHYLPOLYSILOXANE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DIMETHYLPOLYSILOXANE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DIMETHYLPOLYSILOXANE suppliers with CEP (COS) on PharmaCompass.
A DIMETHYLPOLYSILOXANE written confirmation (DIMETHYLPOLYSILOXANE WC) is an official document issued by a regulatory agency to a DIMETHYLPOLYSILOXANE manufacturer, verifying that the manufacturing facility of a DIMETHYLPOLYSILOXANE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DIMETHYLPOLYSILOXANE APIs or DIMETHYLPOLYSILOXANE finished pharmaceutical products to another nation, regulatory agencies frequently require a DIMETHYLPOLYSILOXANE WC (written confirmation) as part of the regulatory process.
click here to find a list of DIMETHYLPOLYSILOXANE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DIMETHYLPOLYSILOXANE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for DIMETHYLPOLYSILOXANE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture DIMETHYLPOLYSILOXANE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain DIMETHYLPOLYSILOXANE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DIMETHYLPOLYSILOXANE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of DIMETHYLPOLYSILOXANE suppliers with NDC on PharmaCompass.
DIMETHYLPOLYSILOXANE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DIMETHYLPOLYSILOXANE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DIMETHYLPOLYSILOXANE GMP manufacturer or DIMETHYLPOLYSILOXANE GMP API supplier for your needs.
A DIMETHYLPOLYSILOXANE CoA (Certificate of Analysis) is a formal document that attests to DIMETHYLPOLYSILOXANE's compliance with DIMETHYLPOLYSILOXANE specifications and serves as a tool for batch-level quality control.
DIMETHYLPOLYSILOXANE CoA mostly includes findings from lab analyses of a specific batch. For each DIMETHYLPOLYSILOXANE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DIMETHYLPOLYSILOXANE may be tested according to a variety of international standards, such as European Pharmacopoeia (DIMETHYLPOLYSILOXANE EP), DIMETHYLPOLYSILOXANE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DIMETHYLPOLYSILOXANE USP).